DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
FG-4592 is an investigational drug.
There have been 26 clinical trials for FG-4592. The most recent clinical trial was a Phase 2 trial, which was initiated on June 11th 2019.
The most common disease conditions in clinical trials are Anemia, Kidney Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are FibroGen, Astellas Pharma Europe B.V., and AstraZeneca.
There are forty-nine US patents protecting this investigational drug and three hundred and seventy-eight international patents.
Recent Clinical Trials for FG-4592
|Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD||AstraZeneca||Phase 3|
|Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD||FibroGen||Phase 3|
|Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients||Second Xiangya Hospital of Central South University||Phase 4|
Top disease conditions for FG-4592
Top clinical trial sponsors for FG-4592
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|FG-4592||Try Before You Buy||Nitrogen-containing heteroaryl compounds and methods of use thereof||FibroGen, Inc. (San Francisco, CA)||Try Before You Buy|
|FG-4592||Try Before You Buy||Crystalline forms of a prolyl hydroxylase inhibitor||FibroGen, Inc. (San Francisco, CA)||Try Before You Buy|
|FG-4592||Try Before You Buy||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Try Before You Buy|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|FG-4592||Austria||AT496033||2023-06-06||Try Before You Buy|
|FG-4592||Australia||AU2004245552||2023-06-06||Try Before You Buy|
|FG-4592||Brazil||BRPI0411055||2023-06-06||Try Before You Buy|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|